The recent successes of large, multicenter clinical trials of acetylcholine
sterase inhibitors for symptomatic treatment of Alzheimer's disease have sp
awned enthusiasm that this common and fatal neurologic disease is "treatabl
e." A parallel explosion has occurred in the consumption of alternative med
icines by the public seeking more effective, natural, or safer methods for
treatment of dementia. Some of these medicines may, in fact, be biologicall
y active in modulating the disease as well as producing side effects and in
teractions with accepted pharmaceuticals. This review brings to focus the s
cientific evidence presently available regarding such agents.